Currently, it has emerged that new pathways, including receptor tyrosine kinases (RTKs) hyper-activation, p53 damage, and autophagy dysfunction, are involved in ccRCC pathogenesis and drug resistance. Here, TP53 is linked to nonpapillary renal cell carcinoma.